• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Belinostat

Belinostat

Product ID B1746
Cas No. 414864-00-9
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $92.90 In stock
10 mg $142.60 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Belinostat is a histone deacetylase (HDAC) inhibitor that exhibits antiviral and anticancer chemotherapeutic activities. Belinostat is approved for use in humans in the treatment of T cell lymphoma and is currently in clinical trials as a potential treatment for other leukemias and lymphomas. In pancreatic cancer cells, belinostat induces apoptosis in an AMPK-dependent manner. In other cellular models, this compound decreases HIV release from macrophages by degrading intracellular HIV.

Product Info

Cas No.

414864-00-9

Purity

≥98%

Formula

C15H14N2O4S

Formula Wt.

318.35

Synonym

PXD101

Solubility

DMSO 64 mg/mL (201.03 mM) Water Insoluble Ethanol Insoluble

Appearance

Pale yellow powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

B1746 MSDS PDF

Info Sheet

B1746 Info Sheet PDF

References

Campbell GR, Bruckman RS, Chu YL, et al. Autophagy Induction by Histone Deacetylase Inhibitors Inhibits HIV Type 1. J Biol Chem. 2015 Feb 20;290(8):5028-40. PMID: 25540204.

Foss F, Advani R, Duvic M, et al. A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma. Br J Haematol. 2014 Nov 17. [Epub ahead of print].
PMID: 25404094.

Kirschbaum MH, Foon KA, Frankel P, et al. A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a California Cancer Consortium Study. Leuk Lymphoma. 2014 Oct;55(10):2301-4. PMID: 24369094.

Wang B, Wang XB, Chen LY, et al. Belinostat-induced apoptosis and growth inhibition in pancreatic cancer cells involve activation of TAK1-AMPK signaling axis. Biochem Biophys Res Commun. 2013 Jul 19;437(1):1-6. PMID: 23743198.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • T8153

    Tunicamycin

    Nucleoside antibiotic mixture; GlcNAc phosphotrans...
    ≥98%
  • B0246

    Balofloxacin Dihydrate

    Fluoroquinolone; bacterial DNA gyrase inhibitor.
    ≥98%
  • A8644

    AVL-292

    BTK inhibitor.
    ≥98%
  • T1674

    Terbutaline Sulfate

    β2-adrenergic agonist, potential ENaC activator.
    ≥98%
  • E537333

    Enniatin A1

    Mycotoxin contaminant found in cereal grains.
    ≥96%
  • M0273

    Mastoparan 8

    Antimicrobial peptide found in bee and wasp venom;...
    ≥95%
  • A4777

    Altiratinib

    c-MET, Tie-2, VEGFR inhibitor.
    ≥98%
  • E6396

    EPZ005687

    EZH2 HMT inhibitor.
    ≥99%
  • K0023

    K252c

    Staurosporine analog; PKC and PKA inhibitor.
    ≥98%
  • T3031

    Thienylbutyl Isothiocyanate

    ITC.
    ≥96%
  • AS106

    Magnolia Standards Kit

    Magnolia Standards Kit Contents: -Column: Cosmosil...
  • P0049

    Pamidronate Disodium Pentahydrate

    Bisphosphonate.
    ≥98%
  • Y4800

    YM-155

    Survivin inhibitor.
    ≥99%
  • C6132

    CPI-203

    Triazolothienodiazepine, JQ-1 derivative; BRD inhi...
    ≥99%
  • C0162

    Capecitabine

    5-FU prodrug; thymidylate synthase inhibitor.
    ≥98%
  • S3584

    Sivelestat Sodium Tetrahydrate

    Neutrophil elastase inhibitor.
    ≥99%
  • P3568

    Pirarubicin

    Anthracycline, DNA intercalator; topoisomerase II ...
    ≥90%
  • P6958

    Protopanaxatriol

    Triterpene sapogenin found in species of Panax; GA...
    ≥95%
  • G1208

    GDC-0879

    V600E B-Raf inhibitor.
    ≥96%
  • P9200

    PX-866

    Wortmannin analog; PI3K inhibitor.
    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only